Autoimmune Polyglandular Syndrome: Symptoms, Diagnosis, and Management
Patients with autoimmune polyglandular syndrome require lifelong hormone replacement therapy for affected glands, annual screening for additional autoimmune diseases, and patient education on stress dosing to prevent life-threatening adrenal crisis.
Clinical Manifestations
Endocrine Symptoms
The most common presentations include:
- Primary adrenal insufficiency (Addison's disease): Fatigue, weight loss, hyperpigmentation, hypotension, salt craving, and severe hyponatremia 1, 2
- Autoimmune thyroid disease: Either hypothyroidism or Graves' disease with associated symptoms 3, 4
- Type 1 diabetes mellitus: Polyuria, polydipsia, weight loss 4
- Hypoparathyroidism: Hypocalcemia, tetany (particularly in APS type 1) 3
- Premature ovarian failure: Amenorrhea, infertility 1
Non-Endocrine Manifestations
- Vitiligo 3
- Pernicious anemia/autoimmune gastritis with vitamin B12 deficiency 1, 5
- Celiac disease 1
- Autoimmune cytopenias (rare) 2
- Autoimmune encephalitis (rare) 5
Critical pitfall: Severe hyponatremia with gastrointestinal symptoms (vomiting, epigastric pain) is often the presenting feature of adrenal insufficiency in APS and is frequently misdiagnosed as primary gastrointestinal or neurological disease 2, 6.
Diagnostic Evaluation
Initial Hormonal Assessment
When APS is suspected, obtain paired morning samples:
- Cortisol and ACTH (elevated ACTH with low cortisol confirms primary adrenal insufficiency) 1
- TSH and free T4 (for thyroid dysfunction)
- Fasting glucose and HbA1c (for diabetes)
- Calcium, phosphate, and PTH (for hypoparathyroidism)
- Plasma renin activity (elevated in mineralocorticoid deficiency) 1
Confirmatory Testing
- ACTH stimulation test: If baseline cortisol is equivocal, this definitively confirms adrenal insufficiency 1
- Anti-CYP21A2 antibodies: Present in autoimmune adrenalitis, can precede clinical disease by years 1
Etiologic Workup
In children with autoimmune PAI, evaluate for APS type 1:
- Screen for hypoparathyroidism and mucocutaneous candidiasis
- Measure anti-interferon antibodies (high sensitivity/specificity) 1
In young males or antibody-negative patients:
- Measure very-long chain fatty acids to exclude adrenoleukodystrophy 1
- Consider CT scan of adrenals to identify infiltrative diseases (tuberculosis, metastases) 1
Screening for Associated Conditions
Annual screening is mandatory for 1:
- Thyroid disease (TSH)
- Type 1 diabetes (fasting glucose, HbA1c)
- Celiac disease (tissue transglutaminase antibodies)
- Autoimmune gastritis (vitamin B12, anti-parietal cell antibodies)
- Premature ovarian failure (FSH, LH in women <40 years)
Management Strategies
Hormone Replacement Therapy
Glucocorticoid Replacement 1:
- Hydrocortisone 15-25 mg/day divided into 2-3 doses
- Largest dose upon awakening
- Second dose after lunch (or at lunch and afternoon for 3-dose regimen)
- Avoid dosing within 4-6 hours of bedtime
- Alternative: Prednisolone 3-5 mg/day once or twice daily (for compliance issues)
- Avoid dexamethasone due to Cushingoid side effects from difficult dose titration 1
Mineralocorticoid Replacement 1:
- Fludrocortisone 100 mcg/day (dose typically remains constant throughout life)
- Infants require sodium chloride supplementation 1-2 g/day (17-34 mmol/day) in first 6 months due to renal mineralocorticoid resistance 1
Thyroid Hormone Replacement:
- Standard levothyroxine dosing based on TSH targets
- Critical: Always correct adrenal insufficiency BEFORE starting thyroid replacement to avoid precipitating adrenal crisis
Other Endocrinopathies:
- Insulin for type 1 diabetes
- Calcium and calcitriol for hypoparathyroidism
- Hormone replacement for premature ovarian failure
Monitoring
Clinical Assessment 1:
- Normal pigmentation restoration
- Stable weight
- Normal blood pressure (orthostatic hypotension indicates insufficient mineralocorticoid)
- Energy levels and quality of life
- Avoid hormonal monitoring of glucocorticoid replacement; adjust based on clinical response only 1
Laboratory Monitoring:
- Serum sodium and potassium
- Plasma renin activity (for mineralocorticoid adequacy)
- Blood pressure monitoring
Follow-up Schedule 1:
- Adults: At least annually with endocrinologist
- Infants: Every 3-4 months (especially first year for blood pressure monitoring)
- Children: Regular assessment for growth and development
Prevention of Adrenal Crisis
Patient Education is Mandatory 1:
Sick Day Rule 1 - Double oral glucocorticoid dose when:
- Fever ≥38°C
- Illness requiring bed rest
- Requiring antibiotics for infection
- Before minor outpatient procedures (dental work)
Sick Day Rule 2 - Injectable hydrocortisone 100 mg (adults) or 50 mg/m² (children) when:
- Unable to tolerate oral medication (vomiting, diarrhea)
- Severe illness or trauma 1
Emergency Supplies:
- All patients must carry injectable hydrocortisone for emergency use
- Steroid emergency card (with diagnosis and treatment instructions)
- Medical alert bracelet stating "Adrenal insufficiency – needs steroids!" 1
Acute Adrenal Crisis Management
Immediate treatment (before test results available) 1:
- Hydrocortisone 100 mg IV bolus (50 mg/m² for children)
- Rapid infusion of 1000 mL isotonic saline within first hour
- Continuous hydrocortisone 200 mg/24 hours IV (50-100 mg/m²/day for children divided q6h)
- For hypoglycemia: Dextrose 0.5-1 g/kg IV
- Taper and switch to oral regimen based on clinical improvement
If hydrocortisone unavailable: Use prednisolone; dexamethasone is least preferred 1
Special Considerations
Pregnancy: Untreated PAI carries high mortality; maintain adequate replacement and increase doses during labor/delivery 1
Surgery:
- Minor/moderate stress: 25-75 mg hydrocortisone/24 hours for 1-2 days
- Major surgery: 100 mg IV bolus, then 200 mg/24 hours continuous infusion 1
Genetic Counseling: Recommended for monogenic disorders (particularly APS type 1) 1
Key Clinical Pearls
The heterogeneity of APS means glandular failures manifest sequentially with large time intervals between first and second disease 4. Screen all patients with one autoimmune endocrinopathy for polyglandular autoimmunity, especially first-degree relatives of APS patients 4. The most prevalent adult combination is type 1 diabetes with autoimmune thyroid disease 4. Early detection of specific autoantibodies and latent organ dysfunction prevents full-blown disease 4, 5.